Chris Rallis - Jul 6, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Stock symbol
FENC
Transactions as of
Jul 6, 2023
Transactions value $
-$18,624
Form type
4
Date filed
7/6/2023, 05:20 PM
Previous filing
Jun 13, 2023
Next filing
Jul 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale -$18.7K -2.21K -7.11% $8.47 28.8K Jul 6, 2023 Direct F1
transaction FENC Common Shares Options Exercise $5.07K +5.28K +18.32% $0.96* 34.1K Jul 6, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise -$5K -5.21K -2.49% $0.96* 204K Jul 6, 2023 Options 5.21K $0.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligation on option exercise.
F2 Shares acquired through the exercise of an option contract with strike price of $0.96 and an expiration date of August 6, 2023.
F3 Represents options granted on August 6, 2013, with a strike price of $0.96 and expiration date of August 6, 2023.